Form D — Outlook Therapeutics, Inc.
0001231919-25-000018 · filed 2025-01-27
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $31,977,359
- Total sold
- $0
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Outlook Therapeutics, Inc.
- CIK
- 1649989
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 111 S. WOOD AVENUE
ISELIN, NJ 08830 - Phone
- 6096193990
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Randy H. Thurman · DirectorIselin, NJ Find on LinkedIn ↗
-
Yezan Haddadin · DirectorIselin, NJ Find on LinkedIn ↗
-
Kurt J. Hilzinger · DirectorIselin, NJ Find on LinkedIn ↗
-
Lawrence A. Kenyon · Executive OfficerIselin, NJ Find on LinkedIn ↗
-
Faisal G. Sukhtian · DirectorIselin, NJ Find on LinkedIn ↗
-
Andong Huang · DirectorIselin, NJ Find on LinkedIn ↗
-
Gerd Auffarth · DirectorIselin, NJ Find on LinkedIn ↗
-
Julian Gangolli · DirectorIselin, NJ Find on LinkedIn ↗
-
Julia A. Haller · DirectorIselin, NJ Find on LinkedIn ↗
-
Jeff Evanson · Executive OfficerIselin, NJ Find on LinkedIn ↗
View original on SEC EDGAR.